MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC)'s Nadya Lisovoder joins Proactive to discuss the results from a clinical study that revealed its clinically-tested food supplement was able to reduce severe symptoms of long Covid.
According to the results, ArtemiC Support had a significant impact on shortness of breath, cough, lack of energy, headache and mental confusion.